Feds Shut Down Off-Label Bone Graft Probe, Medtronic Says
Federal prosecutors have ended their civil and criminal investigation into allegations of off-label marketing of Medtronic Inc.'s Infuse bone graft product, the company said Wednesday, days after a whistleblower False Claims...To view the full article, register now.
Already a subscriber? Click here to view full article